Search Results - Champion, Karlena

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    A randomised, two-arm (1:1 ratio), double blind, placebo controlled phase III trial to assess the efficacy, safety, cost and cost-effectiveness of Rituximab in treating de novo or relapsing NS in patients with MCD/FSGS (TURING)

    A randomised, two-arm (1:1 ratio), double blind, placebo controlled phase III trial to assess the efficacy, safety, cost and cost-effectiveness of Rituximab in treating de novo or... by C Willcocks, Lisa, Qian, Wendi, Cader, Ruzaika, Gatley, Katrina, Siddiqui, Hira, Tabebisong, Endurance, Champion, Karlena, Kronbichler, Andreas, Lightstone, Liz, Jayne, David, Wilson, Edward, Griffith, Megan

    Published in BMC nephrology
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    A randomised, two-arm

    A randomised, two-arm by C Willcocks, Lisa, Qian, Wendi, Cader, Ruzaika, Gatley, Katrina, Siddiqui, Hira, Tabebisong, Endurance, Champion, Karlena, Kronbichler, Andreas, Lightstone, Liz, Jayne, David, Wilson, Edward, Griffith, Megan

    Published in BMC nephrology
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: